ClinPhone, a Clinical Technology Organization (CTO) and Cytel Inc., a company providing statistical services for adaptive clinical trials, have formed a partnership that unites Cytel’s validated adaptive trial statistical and computational expertise with ClinPhone’s robust suite of clinical technologies and operational know-how. This new partnership offers sponsors the combined expertise of the two organizations for the design, planning and implementation of adaptive and other complex study designs. ClinPhone-Cytel adaptive trial solutions are tailored to the requirements and objectives of each individual clinical development program. This integrated service provides all the essential components for adaptive trial planning and implementation, including study design consulting, trial simulations, supplies planning and management, clinical data collection, randomization, trial supply management, data analysis and reporting. Adaptive Clinical Trials (ACTs) refer to clinical studies that use accumulating response data to optimize pre-determined aspects of the study design without undermining the validity and integrity of the trial. By making mid-course adjustments to the trial, adaptive trials increase the ability to answer the study’s key research objectives, and improve the likelihood of a successful outcome.
